These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28380394)

  • 1. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
    Wei W; Liu Q; Li ZZ; Shi WK; Fu X; Liu J; Zhu X; Wang XC; Xu N; Li TF; Jiang FR; Xiao ZP; Zhu HL
    Eur J Med Chem; 2017 Jun; 133():62-68. PubMed ID: 28380394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
    Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
    Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosyl-tRNA synthetase inhibitors: a patent review.
    Sun J; Lv PC; Zhu HL
    Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
    Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Forms of Tyrosyl-tRNA Synthetase from
    Hughes CA; Gorabi V; Escamilla Y; Dean FB; Bullard JM
    SLAS Discov; 2020 Oct; 25(9):1072-1086. PubMed ID: 32583746
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
    Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Wang XD; Deng RC; Dong JJ; Peng ZY; Gao XM; Li ST; Lin WQ; Lu CL; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2013 Sep; 21(17):4914-22. PubMed ID: 23891164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.
    Wang XD; Wei W; Wang PF; Yi LC; Shi WK; Xie YX; Wu LZ; Tang N; Zhu LS; Peng J; Liu C; Li XH; Tang S; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Aug; 23(15):4860-4865. PubMed ID: 26048027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Compounds as Inhibitors of Tyrosyl-tRNA Synthetase.
    Skupińska M; Stępniak P; Łętowska I; Rychlewski L; Barciszewska M; Barciszewski J; Giel-Pietraszuk M
    Microb Drug Resist; 2017 Apr; 23(3):308-320. PubMed ID: 27487455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
    Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
    Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.
    Wang XD; Wei W; Wang PF; Tang YT; Deng RC; Li B; Zhou SS; Zhang JW; Zhang L; Xiao ZP; Ouyang H; Zhu HL
    Bioorg Med Chem; 2014 Jul; 22(14):3620-8. PubMed ID: 24882676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
    Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Kadri A; Snoussi M
    Bioorg Chem; 2020 Sep; 102():104105. PubMed ID: 32717689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and activity of analogues of SB-219383: novel potent inhibitors of bacterial tyrosyl tRNA synthetase.
    Berge JM; Broom NJ; Houge-Frydrych CS; Jarvest RL; Mensah L; McNair DJ; O'Hanlon PJ; Pope AJ; Rittenhouse S
    J Antibiot (Tokyo); 2000 Nov; 53(11):1282-92. PubMed ID: 11213289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
    Guo ZH; Yin Y; Wang C; Wang PF; Zhang XT; Wang ZC; Zhu HL
    Bioorg Med Chem; 2015 Sep; 23(18):6148-56. PubMed ID: 26304108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural snapshots of the KMSKS loop rearrangement for amino acid activation by bacterial tyrosyl-tRNA synthetase.
    Kobayashi T; Takimura T; Sekine R; Kelly VP; Kamata K; Sakamoto K; Nishimura S; Yokoyama S
    J Mol Biol; 2005 Feb; 346(1):105-17. PubMed ID: 15663931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.